miR-21过表达与淋巴瘤诊治

摘要: 微小RNA（microRNA，miRNA）是一类长20~25 nt的非编码RNA，广泛存在真核生物中。miRNA的表达呈现进化保守性、时序性及组织细胞特异性，并参与细胞生长、增殖、分化和凋亡等过程，miRNA的表达与多种肿瘤发病相关，具有肿瘤抑制因子及癌基因的作用。miR-21是在肿瘤中常见的过表达miRNA，在多种肿瘤组织中呈现高表达，其在淋巴瘤中也表达升高，并通过多种方式影响肿瘤抑癌基因及相关信号通路促进淋巴瘤的发生，影响肿瘤的进展及预后。使用转染反义寡核苷酸等分子生物学方法降低miR-21的表达可以抑制肿瘤细胞的生长等生物学的行为并提高肿瘤细胞对化疗的敏感性，深入研究miR-21在淋巴瘤中的作用有望为淋巴瘤的发病机制及治疗等方面提供新的思路。本文对miR-21在淋巴瘤中的表达情况，及其调控因素、作用机制、靶位点及与临床诊断治疗预后的关系进行综述。
- miR-21 /
- 淋巴瘤 /
- miRNA
Abstract: Microribonucleic acids (miRNAs) are 20 nt to 25 nt non-coding RNAs that are widely distributed in eukaryotes. MiRNAs regulate gene expression in a sequence-specific manner and regulate diverse expression patterns that are dependent on cell status and identity. MiRNAs function as gene regulators, controlling many cellular processes such as cell growth, differentiation, proliferation, and apoptosis. MiRNA expression is also reportedly correlated with many cancers, by acting as oncogenes or tumor suppressors. MiR-21 is overexpressed in many kinds of tumors, including human lymphomas. MiR-21 promotes tumorigenesis and affects tumor progression and prognosis through a variety of ways by influencing tumor suppressor genes and related signaling pathways. MiR-21 silencing using an antisense nucleotide increases the sensitivity of lymphoma cells to chemotherapy and inhibits the growth of tumor cells. Therefore, studying miR-21 may provide new insights into the pathogenesis and treatment of lymphoma. In this review, the authors summarized the current knowledge on the significance of miR-21 in human lymphomas, with an emphasis on its regulation, mechanism of action, target sites in human lymphoma cells, and its potential as a disease biomarker and novel therapeutic target.
- miR-21 /
- lymphoma /
- miRNA

HTML全文

参考文献(25)

[1]	Farazi TA, Spitzer JI, Morozov P, et al. miRNAs in human cancer [J]. J Pathol, 2011, 223(2):102-115. doi: 10.1002/path.2806
[2]	Martinez I, Dimaio D. B-Myb, cancer, senescence, and microRNAs [J]. Cancer Res, 2011, 1(16):5370-5373. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=6352ccbcc8146ca4683bf11a3452afe2
[3]	Meister G, Tuschl T. Mechanisms of gene silencing by double-stranded RNA[J]. Nature, 2004, 431(7006):343-349. doi: 10.1038/nature02873
[4]	Wu L, Fan J, Belasco JG. MicroRNAs direct rapid deadenylation of mRNA[J]. Proc Natl Acad Sci U S A, 2006, 103(11):4034-4039. doi: 10.1073/pnas.0510928103
[5]	Li LC, Okino ST, Zhao H, et al. Small dsRNAs induce transcriptional activation in human cells[J]. Proc Natl Acad Sci U S A, 2006, 103(46):17337-17342. doi: 10.1073/pnas.0607015103
[6]	Lawrie CH, Soneji S, Marafioti T, et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma[J]. Int J Cancer, 2007, 121(5):1156-1161. doi: 10.1002/ijc.22800
[7]	Navarro A, Gaya A, Martinez A, et al. MicroRNA expression profiling in classic Hodgkin lymphoma[J]. Blood, 2008, 111(5):2825-2832. doi: 10.1182/blood-2007-06-096784
[8]	Baraniskin A, Kuhnhenn J, Schlegel U, et al. Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system[J]. Blood, 2011, 117 (11):3140-3146. doi: 10.1182/blood-2010-09-308684
[9]	Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma[J]. Nature, 2010, 467(7311):86-90. doi: 10.1038/nature09284
[10]	Thapa DR, Bhatia K, Bream JH, et al. B-cell activation induced microRNA-21 is elevated in circulating B cells preceding the diagnosis of AIDS-related non-Hodgkin lymphomas[J]. AIDS, 2012, 26 (9):1177-1180. doi: 10.1097/QAD.0b013e3283543e0e
[11]	Arribas AJ, Gómez-Abad C, Sánchez-Beato M, et al. Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling[J]. Mod Pathol, 2013, 26(7):889-901. doi: 10.1038/modpathol.2012.220
[12]	Ge TT, Liang Y, Fu R, et al. Expressions of miR-21, miR-155 and miR-210 in plasma of patients with lymphoma and its clinical significance[J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2012, 20(2): 305-309. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgsyxyxzz201202016
[13]	Rosato P, Anastasiadou E, Garg N, et al. Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2[J]. Leukemia, 2012, 26(11):2343-2352. doi: 10.1038/leu.2012.108
[14]	Mathé E, Nguyen GH, Funamizu N, et al. Inflammation regulates microRNA expression in cooperation with p53 and nitric oxide[J]. Int J Cancer, 2012, 131(3):760-765. doi: 10.1002/ijc.26403
[15]	Liu C, Gao F, Li B, et al. TLR4 knockout protects mice from radiation-induced thymic lymphoma by downregulation of IL6 and miR-21[J]. Leukemia, 2011, 25(9):1516-1519. doi: 10.1038/leu.2011.113
[16]	van der Fits L, van Kester MS, Qin Y, et al. MicroRNA-21 expression in CD4+T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome[J]. J Invest Dermatol, 2011, 131(3): 762-768.
[17]	Zhang Q, Wang HY, Liu X, et al. IL-2R common gamma-chain is epigenetically silenced by nucleophosphin-anaplastic lymphoma kinase (NPM-ALK) and acts as a tumor suppressor by targeting NPM-ALK[J]. Proc Natl Acad Sci U S A, 2011, 108(29):11977-11982. doi: 10.1073/pnas.1100319108
[18]	Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA [J]. J Cell Mol Med, 2009, 13(1):39-53. http://cn.bing.com/academic/profile?id=8b10584800b1baebaa8d36cccc0f3872&encoded=0&v=paper_preview&mkt=zh-cn
[19]	Buscaglia LE, Li Y. Apoptosis and the target genes of microRNA-21 [J]. Chin J Cancer, 2011, 30(6):371-380. doi: 10.5732/cjc.30.0371
[20]	Liu C, Li B, Chen Y, et al. MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3[J]. Int J Biol Sci, 2011, 7(3):347-363. doi: 10.7150/ijbs.7.347
[21]	Yamanaka Y, Tagawa H, Takahashi N, et al. Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia[J]. Blood, 2009, 114(15):3265-3275. doi: 10.1182/blood-2009-06-222794
[22]	Bai H, We J, Deng C, et al. MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen[J]. Int J Hematol, 2013, 97(2):223-231. doi: 10.1007/s12185-012-1256-x
[23]	Baraniskin A, Kuhnhenn J, Schlegel U, et al. MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma[J]. J Neurooncol, 2012, 109(2): 239-244. doi: 10.1007/s11060-012-0908-2
[24]	Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma[J]. Br J Haematol, 2008, 141(5):672-675. doi: 10.1111/j.1365-2141.2008.07077.x
[25]	Fu X, Han Y, Wu Y, et al. Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis[J]. Eur J Clin Invest, 2011, 41(11):1245-1253. doi: 10.1111/j.1365-2362.2011.02535.x